The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10148 malaria professionals are enjoying the free benefits of MalariaWorld today

mycobactin

Communication: Design, Synthesis, and Study of a Mycobactin−Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria

January 31, 2011 - 10:24 -- Patrick Sampao
Author(s): 
Marvin J. Miller., Andrew J. Walz., Helena I. Boshoff., et al.
Reference: 
Journal of the American Chemical Society

The result is that one appropriate conjugate has potent and selective activity against two of the most deadly diseases in the world.

Medical Condition: 
Medical Treatment: 
Subscribe to RSS - mycobactin